Codeine linctus to be reclassified to a prescription-only medicine

by | Feb 20, 2024 | Blog, Pharmacy

A press release from the MHRA today, 20th February 2024, has announced that Codeine linctus will be reclassified as a prescription only medicine because of the risk of abuse and addiction. Read the full press release here

Codeine Linctus is an opioid medicine which has been previously available as a medicine sold under the supervision of a pharmacist (a P medicine), but will now only be available as prescription only.

There have been increasing reports that the drug has been misused as an ingredient in a recreational drink which can be known as “Lean”, “Purple Drank”, “Sizzurp” and more. There is a risk of overdose particularly due to the use of codeine in unknown quantities taken in combination with alcohol.

The MHRA ran a consultation in July/August 2023 to propose the reclassification of Codeine Linctus to prescription-only medicine. For more information about the consultation see here

Contact us to see if we can help you.


Both Jackie and Sandeep made it really easy to understand the content – they encouraged discussion but also made sure that focus was given to areas specific to the attendees. Overall I enjoyed the course and found it far less overwhelming than I expected.
Cogent Gold Standard Training